Investors considering Monopar should keep a close eye out for announcements about further development of ALXN-1840. Any updates on its MNPR-101 line of oncology products, all of which are either in ...
"I still think it is a bull market. I still think the primary trend is higher. If we're right on growth, if we're right on ...
Analysts at StockNews.com began coverage on shares of NantHealth (NASDAQ:NH – Get Free Report) in a research report issued on Wednesday. The firm set a “hold” rating on the stock. NantHealth Stock Up ...
The Nasdaq and S&P 500 edged higher on Tuesday as tech-related shares extended recent gains and investors digested reassuring ...
ET, markets are largely flat on the day. Here's a check-in on major indexes: Nasdaq: Up 9.82(+.05%) S&P 500: Down 3.86 (-.06% ...